Vladan Milosevic, Reidunn J. Edelmann, Ingeborg Winge, Carina Strell, Artur Mezheyeuski, Gøril Knutsvik, Cecilie Askeland, Elisabeth Wik, Lars A. Akslen, Arne Östman: Vessel size as a marker of survival in estrogen receptor positive breast cancer. In: Breast Cancer Research and Treatment. Band200, Nr.2, Juli 2023, ISSN0167-6806, S.293–304, doi:10.1007/s10549-023-06974-4 (springer.com [abgerufen am 20. Januar 2024]).
Lars Tore Gyland Mikalsen, Hari Prasad Dhakal, Øyvind S. Bruland, Bjørn Naume, Elin Borgen, Jahn M. Nesland, Dag Rune Olsen: The Clinical Impact of Mean Vessel Size and Solidity in Breast Carcinoma Patients. In: PLOS ONE. Band8, Nr.10, 10. November 2013, ISSN1932-6203, S.e75954, doi:10.1371/journal.pone.0075954, PMID 24146798, PMC 3795733 (freier Volltext) – (plos.org [abgerufen am 20. Januar 2024]).
Vladan Milosevic, Reidunn J. Edelmann, Ingeborg Winge, Carina Strell, Artur Mezheyeuski, Gøril Knutsvik, Cecilie Askeland, Elisabeth Wik, Lars A. Akslen, Arne Östman: Vessel size as a marker of survival in estrogen receptor positive breast cancer. In: Breast Cancer Research and Treatment. Band200, Nr.2, Juli 2023, ISSN0167-6806, S.293–304, doi:10.1007/s10549-023-06974-4 (springer.com [abgerufen am 20. Januar 2024]).
Barbara Klencke, Saveri Bhattacharya, Meghna Samant, Julie R. Gralow, Maura N. Dickler, Melody A. Cobleigh, Edith A. Perez, Tamara N. Shenkier, Nancy E. Davidson, Kathy D. Miller: Independent review of E2100 progression-free survival (PFS) with the addition of bevacizumab (B) to paclitaxel (P) as initial chemotherapy for metastatic breast cancer (MBC). In: Journal of Clinical Oncology. 2008, Band 26, Nummer 15_suppl, S. 1036 doi:10.1200/jco.2008.26.15_suppl.1036.
Thomas H. Adair, Jean-Pierre Montani: Angiogenesis. Morgan & Claypool Life Sciences, San Rafael, CA 2010.
Lars Tore Gyland Mikalsen, Hari Prasad Dhakal, Øyvind S. Bruland, Bjørn Naume, Elin Borgen, Jahn M. Nesland, Dag Rune Olsen: The Clinical Impact of Mean Vessel Size and Solidity in Breast Carcinoma Patients. In: PLOS ONE. Band8, Nr.10, 10. November 2013, ISSN1932-6203, S.e75954, doi:10.1371/journal.pone.0075954, PMID 24146798, PMC 3795733 (freier Volltext) – (plos.org [abgerufen am 20. Januar 2024]).
N. Almog: Molecular mechanisms underlying tumor dormancy. In: Cancer Lett. 294, 2010, S. 139–146. PMID 20363069
O. Benny, O. Fainaru, A. Adini, F. Cassiola, L. Bazinet, I. Adini, E. Pravda, Y. Nahmias, S. Koirala, G. Corfas, R. J. D’Amato, J. Folkman: An orally delivered small-molecule formulation with antiangiogenic and anticancer activity. In: Nat Biotechnol. 26(7), Jul 2008, S. 799–807. Epub 2008 Jun 29. PMID 18587385
plos.org
journals.plos.org
Lars Tore Gyland Mikalsen, Hari Prasad Dhakal, Øyvind S. Bruland, Bjørn Naume, Elin Borgen, Jahn M. Nesland, Dag Rune Olsen: The Clinical Impact of Mean Vessel Size and Solidity in Breast Carcinoma Patients. In: PLOS ONE. Band8, Nr.10, 10. November 2013, ISSN1932-6203, S.e75954, doi:10.1371/journal.pone.0075954, PMID 24146798, PMC 3795733 (freier Volltext) – (plos.org [abgerufen am 20. Januar 2024]).
Vladan Milosevic, Reidunn J. Edelmann, Ingeborg Winge, Carina Strell, Artur Mezheyeuski, Gøril Knutsvik, Cecilie Askeland, Elisabeth Wik, Lars A. Akslen, Arne Östman: Vessel size as a marker of survival in estrogen receptor positive breast cancer. In: Breast Cancer Research and Treatment. Band200, Nr.2, Juli 2023, ISSN0167-6806, S.293–304, doi:10.1007/s10549-023-06974-4 (springer.com [abgerufen am 20. Januar 2024]).
Vladan Milosevic, Reidunn J. Edelmann, Ingeborg Winge, Carina Strell, Artur Mezheyeuski, Gøril Knutsvik, Cecilie Askeland, Elisabeth Wik, Lars A. Akslen, Arne Östman: Vessel size as a marker of survival in estrogen receptor positive breast cancer. In: Breast Cancer Research and Treatment. Band200, Nr.2, Juli 2023, ISSN0167-6806, S.293–304, doi:10.1007/s10549-023-06974-4 (springer.com [abgerufen am 20. Januar 2024]).
Vladan Milosevic, Reidunn J. Edelmann, Ingeborg Winge, Carina Strell, Artur Mezheyeuski, Gøril Knutsvik, Cecilie Askeland, Elisabeth Wik, Lars A. Akslen, Arne Östman: Vessel size as a marker of survival in estrogen receptor positive breast cancer. In: Breast Cancer Research and Treatment. Band200, Nr.2, Juli 2023, ISSN0167-6806, S.293–304, doi:10.1007/s10549-023-06974-4 (springer.com [abgerufen am 20. Januar 2024]).
Lars Tore Gyland Mikalsen, Hari Prasad Dhakal, Øyvind S. Bruland, Bjørn Naume, Elin Borgen, Jahn M. Nesland, Dag Rune Olsen: The Clinical Impact of Mean Vessel Size and Solidity in Breast Carcinoma Patients. In: PLOS ONE. Band8, Nr.10, 10. November 2013, ISSN1932-6203, S.e75954, doi:10.1371/journal.pone.0075954, PMID 24146798, PMC 3795733 (freier Volltext) – (plos.org [abgerufen am 20. Januar 2024]).
Vladan Milosevic, Reidunn J. Edelmann, Ingeborg Winge, Carina Strell, Artur Mezheyeuski, Gøril Knutsvik, Cecilie Askeland, Elisabeth Wik, Lars A. Akslen, Arne Östman: Vessel size as a marker of survival in estrogen receptor positive breast cancer. In: Breast Cancer Research and Treatment. Band200, Nr.2, Juli 2023, ISSN0167-6806, S.293–304, doi:10.1007/s10549-023-06974-4 (springer.com [abgerufen am 20. Januar 2024]).